E-LIB Suche - Ergebnisse für: Hizal, Mutlu

1

Interleukin-21 and Interleukin-23 levels in familial Medite..:

Hizal, Mutlu ; Tufan, Abdurrahman ; Mercan, Ridvan...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

External Validation of a Novel Risk Model in Patients With ..:

Yekedüz, Emre ; Karakaya, Serdar ; Ertürk, İsmail...
Clinical Genitourinary Cancer. 21 (2023) 1 - p. 175-182 , 2023

Link: https://doi.org/10.1016/..

3

Atezolizumab combined with chemotherapy in the first-line t..:

Gürbüz, Mustafa ; Kutlu, Yasin ; Akkuş, Erman...
Journal of Cancer Research and Clinical Oncology. 148 (2022) 12 - p. 3547-3555 , 2022

Link: https://doi.org/10.1007/..

4

The percentage of ALK-positive cells and the efficacy of fi..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 4141-4148 , 2022

Link: https://doi.org/10.1007/..

5

The real-life efficacy and safety of osimertinib in pretrea..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology. 148 (2021) 6 - p. 1501-1508 , 2021

Link: https://doi.org/10.1007/..

6

The effect of EML4-ALK break-apart ratio on crizotinib outc..:

Bilgin, Burak ; Şendur, Mehmet Ali Nahit ; Yücel, Şebnem...
Journal of Cancer Research and Clinical Oncology. 147 (2021) 9 - p. 2637-2643 , 2021

Link: https://doi.org/10.1007/..

7

Real-life comparison of the afatinib and first-generation t..:

Bilgin, Burak ; Sendur, Mehmet Ali Nahit ; Yucel, Sebnem...
Journal of Cancer Research and Clinical Oncology. 147 (2021) 7 - p. 2145-2152 , 2021

Link: https://doi.org/10.1007/..

8

Neutrophil–lymphocyte ratio as a prognostic factor for surv..:

Hizal, Mutlu ; Sendur, Mehmet AN ; Yasar, Hatime Arzu...
Journal of Oncology Pharmacy Practice. 26 (2020) 7 - p. 1583-1589 , 2020

Link: https://doi.org/10.1177/..

9

Evaluation of dynamic serum thiol-disulphide homeostasis in..:

Bilgin, Burak ; Sendur, Mehmet AN. ; Hizal, Mutlu...
Journal of Oncological Sciences. 5 (2019) 2 - p. 60-64 , 2019

Link: https://doi.org/10.1016/..

10

The relationship between prognostic nutritional index and t..:

Yasar, Hatime Arzu ; Bir Yucel, Kadriye ; Arslan, Cagatay...
Journal of Oncology Pharmacy Practice. 26 (2019) 5 - p. 1110-1116 , 2019

Link: https://doi.org/10.1177/..

11

Evaluation of dynamic serum thiol/disulfide homeostasis in ..:

Hizal, Mutlu ; Sendur, Mehmet A.N. ; Bilgin, Burak...
Journal of Oncological Sciences. 4 (2018) 1 - p. 1-4 , 2018

Link: https://doi.org/10.1016/..

12

Decrease of LL-37 in systemic sclerosis: a new marker for i..:

Hizal, Mutlu ; Bruni, Cosimo ; Romano, Eloisa...
Clinical Rheumatology. 34 (2015) 4 - p. 795-798 , 2015

Link: https://doi.org/10.1007/..

13

Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuv..:

ÜRÜN, YÜKSEL ; EROL, CİHAN ; HAFIZOĞLU, EMRE...
1d184dd9-f0da-4ec0-be0b-ad7ee343f7ac. , 2023

Link: https://doi.org/10.5505/..

14

The percentage of ALK-positive cells and the efficacy of fi..:

Aydiner, Adnan ; Ayhan, Murat ; KESKİNKILIÇ, MERVE...
c660c78b-2ee2-43de-ab96-b732abd5a4c2. , 2023

Link: https://doi.org/10.1007/..

15

Treatment efficacy of ribociclib or palbociclib plus letroz..:

Ozkanli, Gulhan ; Duman, Berna Bozkurt ; Aydin, Dincer...
Future Oncology. , 2023

Link: https://hdl.handle.net/1..